Skip to content
Search

Latest Stories

FEATURE: Helping beat the winter blues

As pharmacy teams brace themselves for a second wave of Covid-19 and a season of cold and flu, superintendent pharmacist Sobha Sharma Kandel offers some expert advice

Winter is imminent and with dropping temperatures viruses are bound to be more prevalent, exacerbating health problems among the vulnerable and immunocompromised patients. This can cause serious complications, and therefore, it’s important to know the symptoms, methods to manage them and when to refer.


A healthy person can usually manage the illnesses with over-the counter medication. Colds, flu and Covid-19 are caused by different viruses. As some of their symptoms overlap, it may be hard to tell the difference. However, some key differences are shown in the following figure.

It is also possible to suffer from cold/flu and Covid-19 simultaneously, which can complicate matters. As per NHS guidelines, anyone with fever, cough, loss/change in sense of taste and/or smell has to self-isolate and request a Covid test.

Pharmacy Advice

The pharmacy team should advise patients with symptoms to take rest, ensure adequate hydration and take balanced nutrition. Supplements such as Vitamin C, Vitamin D and zinc can also help to boost the immune system and can be recommended.

Pharmacy teams can recommend analgesics such as paracetamol or ibuprofen to help relieve associated muscle pain and headaches, and lower temperature. Paracetamol has an analgesic (painkilling), as well as an antipyretic effect (works on the brain to bring down a fever). It is a safe drug. However, an overdose can be dangerous, and therefore, the pharmacy team should check if the patient is on any other medication that has paracetamol.

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen also inhibits prostaglandins. It has anti-inflammatory, analgesic and antipyretic activity.

The main problem with NSAIDs is their irritant effect on the gastrointestinal system. It should be taken with food and should not be taken by patients with a history of stomach ulcer, indigestion, asthma or kidney disease.

Oral or nasal decongestants reduce nasal swelling and may help ease breathing but should not be used for longer than seven days because they can aggravate congestion. They should also not be used at night as they can inhibit sleep.

Nice guideline suggests honey could be effective in reducing acute coughs except for children under 12 months of age. Other remedies include the herbal remedy pelargonium, and cough medicines containing either guaifenesin or antitussive dextromethorphan (for 12 years and above).

Lozenges, anaesthetic spray or anti-inflammatory spray can be used. Gargling with antiseptic mouth rinse or salt water (not for children) and taking warm drinks with honey can help. Severe sore throat pain and difficulty in swallowing must be referred to a GP as tonsillitis and antibiotics may be needed.

Advice for children

Ensure adequate hydration and rest. Products to recommend: A thermometer to monitor temperature, saline nasal drops or sprays for nasal congestion, analgesics like paracetamol, ibuprofen, glycerin-based cough syrups, topical rubs, and humidifier in the room.

The majority of cold and flu symptoms will clear up in four to five days. However, complete recovery from a cold or flu can take between 10-14 days. Post viral fatigue can also last a couple of weeks. Colds are much more common than flu and less severe.

Many OTC cold and cough medicines contain combinations of analgesics, decongestants and cough suppressants to relieve multiple symptoms; therefore, the pharmacy team needs to advice patients to not take any other remedies with same ingredients to prevent overdose.

Pharmacists and their staff have an essential role to play as they are the first port of call for patients. They should provide reassurance, give advice and recommend safe products and have an important function of signposting or referring patients if and when needed.

Sobha Sharma Kandel is superintendent pharmacist of Neem Tree Pharmacy in London.

This feature also appears in the print edition of Pharmacy Business/Oct 2020. 

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less